Email this article IMPORTANCE OF INSULIN-LIKE AND VASCULAR AND ENDOTHELIAL GROWTH FACTORS IN THE PATHOGENESIS OF POLYCYSTIC OVARY SYNDROME (REVIEW OF LITERATURE)
- Authors: Kuzina O.V.1, Sosnova E.A1
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University
- Issue: Vol 6, No 2 (2019)
- Pages: 80-84
- Section: Original study articles
- URL: https://journals.rcsi.science/2313-8726/article/view/43000
- DOI: https://doi.org/10.18821/2313-8726-2019-6-2-80-84
- ID: 43000
Cite item
Full Text
Abstract
The study of various mechanisms of the pathogenesis of polycystic ovary syndrome (PCOS) shows the multifactorial nature of its development with the involvement of many organs and systems, as well as growth factors that are actively involved in the growth and proliferation processes of both normal and pathologically altered biological tissues, including the ovaries, not only with PCOS, but also with endometriosis and tumor formations. The article discusses new data on the involvement of insulin-like and vascular endothelial growth factors in the pathogenesis of PCOS. The study of their role is relevant and promising task.
Full Text
##article.viewOnOriginalSite##About the authors
Olga V. Kuzina
I.M. Sechenov First Moscow State Medical University
Email: olga.kuzina.95@mail.ru
6th year student of I.M. Sechenov First Moscow State Medical University, Moscow, 119991, Russian Federation Moscow, 119991, Russian Federation
E. A Sosnova
I.M. Sechenov First Moscow State Medical UniversityMoscow, 119991, Russian Federation
References
- Балаболкин М.И. Эндокринология. М.: Медицина; 1989.
- Жмакин К.Н. Гинекологическая эндокринология. М.: Медицина; 1980: 75-7.
- Barbieri R.L., Makris A., Randall R.W. et al. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J. Clin. Endocrinol. Metab. 1986; 62 (5): 904-9.
- Barbieri R.L., Ryan K.J. Hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome: a common endocrinopathy with distinct pathophysiologic features. Am. J. Obstet. Gynecol. 1983; 147 (1): 90-101.
- Barbieri R.L., Smith S., Ryan K.J. The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism. Fertil. Steril. 1988; 50 (2):197-212.
- Baserga R. The biology of cell reproduction. Cambridge (MA): Harvard University Press; 1985: 46-58.
- Bergh C., Carlsson B., Olsson J.H., Sellskog U., Hillensjo T. Regulation of androgen production in cultured human thecal cells by insulin-like growth factor-I and insulin. Fertil. Steril. 1993; 52: 323-31.
- Berkman R.A., Merrill M.J., Reinhold W.C. et al. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J. Clin. Invest. 1993; 91:153-9.
- Berse B., Brown L.F., Van De Water L. et al. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol. Biol. Cell. 1992; 3: 211-20.
- Brannstrom M., Norman R., Seamark R., Robertson S. Rat ovary produces cytokines during ovulation. Biol. Reprod. 1994; 50: 88-94.
- Brock T.A., Dvorak H.F., Senger D.R. Tumor-secreted permeability factor increased scytosolic Ca2+ and von Willebrand factor release in human endothelial cells. Am. J. Pathol. 1991; 138: 213-21.
- Бурлев В.А., Гаспаров А.С., Аванесян Н.С., Волков Н.И., Стыгар Д.А. Факторы роста и их роль в регуляции репродуктивной функции у больных с синдромом поликистозных яичников. Пробл. репрод. 1998; (3): 17-25.
- Agrawal R., Chimusoro K., Payne N. et al. Severe ovarian hyperstimulation syndrome: serum and ascitic fluid concentrations of vascular endothelial growth factor. Curr. Opin. Obstet. Gynecol. 1997; 9(2): 141-4.
- Agrawal R., Tan S.L., Wild S., Sladkevicius P. et al. Serum vascular endothelial growth factor concentrations in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome. Fertil. Steril. 1999; 71(2): 287-93.
- Zalel Y., Orvieto R., Ben-Rafael Z., Homburg R., Fisher O., Insler V. Recurrent spontaneous ovarian hyperstimulation syndrome associated with polycystic ovary syndrome. Gynecol. Endocrinol. 1995; 9: 313-5.
Supplementary files
